false
Catalog
2023 World Conference on Lung Cancer (Posters)
EP02.04. The Suppressed Peritumoral Immune Microen ...
EP02.04. The Suppressed Peritumoral Immune Microenvironment Enhances the Progression of Primary Lung Cancer And Metastatic Liver Tumor - PDF(Slides)
Back to course
Pdf Summary
Researchers from Kaohsiung Medical University in Taiwan have conducted a study to explore the peritumoral immune microenvironment (pTME) of primary lung tumors and metastatic liver tumors in order to better understand tumor progression and identify potential treatment strategies. Lung cancer is the leading cause of cancer-related deaths worldwide, and liver metastases occur in 12% of lung cancer patients, leading to poorer outcomes.<br /><br />Using a mouse model injected with a Lewis lung carcinoma cell line, the researchers analyzed the transcriptomic profiles of the primary lung tumors, hepatic metastatic tumors, and their surrounding tissues using spatial next-generation sequencing. They found that the pTME in both the lung and liver were immuno-suppressive and promotive for tumor progression. In the lung, Scd1-expressing M2 macrophages were found to contribute to tumor growth, while in the liver, Mt1/Mt2 expressing hepatocytes and Bregs were identified as key players in promoting tumor progression.<br /><br />The study highlights the importance of the pTME in cancer progression and suggests that targeting the immune interactions in the microenvironment could be an effective treatment strategy for lung cancer with liver metastasis. Additionally, the findings could potentially be used as novel diagnostic and prognostic biomarkers for these types of cancer.<br /><br />Overall, this research provides valuable insights into the peritumoral immune microenvironment of primary lung tumors and metastatic liver tumors and has implications for the development of new treatment approaches in lung cancer with liver metastasis.
Asset Subtitle
KUAN-LI WU
Meta Tag
Speaker
KUAN-LI WU
Topic
Tumor Biology: Preclinical Biology - Tumor Immunity
Keywords
peritumoral immune microenvironment
lung tumors
liver tumors
tumor progression
treatment strategies
lung cancer
liver metastases
mouse model
transcriptomic profiles
spatial next-generation sequencing
×
Please select your language
1
English